Evidence map›Paper›PMID 28217782›Full record

ArticleIntegrative biology : quantitative biosciences from nano to macro2017

Receptor for hyaluronan mediated motility (RHAMM/HMMR) is a novel target for promoting subcutaneous adipogenesis.

S B Bahrami, C Tolg, T Peart, C Symonette, M Veiseh, J U Umoh, D W Holdsworth, J B McCarthy, L G Luyt, M J Bissell and 2 more

Abstract read
In one paragraph

Article in Integrative biology : quantitative biosciences from nano to macro, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. "Annals of pancreatic cancer · 2022
    Article
  8. Article
  9. RHAMM Is a Multifunctional Protein That Regulates Cancer Progression.International journal of molecular sciences · 2021
    Review
  10. Article
  11. Article
  12. [Paradigm shift in understanding hyaluronic acid filler effects].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. Hyaluronan in adipogenesis, adipose tissue physiology and systemic metabolism.Matrix biology : journal of the International Society for Matrix Biology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 4 countries.

S B BahramiBiological Systems and Engineering Division, BioSciences Area, Lawrence Berkeley National Laboratories, 977R225A, Berkeley, CA 94720, USA.
C Tolg
T Peart
C Symonette
M Veiseh
J U Umoh
D W Holdsworth
J B McCarthy
L G Luyt
M J Bissell
A Yazdani
E A Turley
Western University · CABerkeley College · USCancer Research UK · GBUniversity of Minnesota · US

Funding

Definition of the Microenvironment in Breast CancerR01CA064786 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI BISSELL, MINA · 1995 to 2020
$6.1M
Bioengineering 3-D Models for Organ-Specific Cancer Therapy in Lung and BreastU54CA126552 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI BISSELL, MINA · 2006 to 2010
$2.2M
Hyaluronan Receptors in Prostate Cancer ProgressionR01CA119092 · NCI · UNIVERSITY OF MINNESOTA · PI MCCARTHY, JAMES B. · 2008 to 2012
$2.2M
Multiplex profiling and targeting of breast tumorigenic progenitor cellsF32CA132491 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI VEISEH, MANDANA · 2008 to 2010
$160k
CIHRNCI NIH HHS F32 CA132491NCI NIH HHS R01 CA064786NCI NIH HHS R01 CA119092NCI NIH HHS U54 CA126552
6 · The paper itself

Abstract

Hyaluronan, CD44 and the Receptor for Hyaluronan-Mediated Motility (RHAMM, gene name HMMR) regulate stem cell differentiation including mesenchymal progenitor differentiation. Here, we show that CD44 expression is required for subcutaneous adipogenesis, whereas RHAMM expression suppresses this process. We designed RHAMM function blocking peptides to promote subcutaneous adipogenesis as a clinical and tissue engineering tool. Adipogenic RHAMM peptides were identified by screening for their ability to promote adipogenesis in culture assays using rat bone marrow mesenchymal stem cells, mouse pre-adipocyte cell lines and primary human subcutaneous pre-adipocytes. Oil red O uptake into fat droplets and adiponectin production were used as biomarkers of adipogenesis. Positive peptides were formulated in either collagen I or hyaluronan (Orthovisc) gels then assessed for their adipogenic potential in vivo following injection into dorsal rat skin and mammary fat pads. Fat content was quantified and characterized using micro CT imaging, morphometry, histology, RT-PCR and ELISA analyses of adipogenic gene expression. Injection of screened peptides increased dorsal back subcutaneous fat pad area (208.3 ± 10.4 mm

Indexed as

AdipocytesAdipogenesisAnimalsCell DifferentiationCell LineDrug Delivery SystemsExtracellular Matrix ProteinsFemaleHumansHyaluronan ReceptorsHyaluronic AcidMesenchymal Stem CellsMiceRatsRats, Sprague-DawleySubcutaneous FatExtracellular Matrix Proteinshyaluronan-mediated motility receptorHyaluronan ReceptorsHyaluronic Acid

Identifiers

PMID28217782
PMCPMC5476222
OpenAlexW2590308841

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.